Position in VYGR
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$79,361
-$65,019 QoQ
Shares Held
20,560
-44.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ethic Inc. holds $32,626,777 across 32 Biotechnology names. VYGR ranks #24 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,017 | $11,602,734 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,896 | $7,991,279 | |
| 3 | ARGX |
Argenx SE
|
4,029 | $2,942,177 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,869 | $1,280,136 | |
| 5 | CYTK |
Cytokinetics Inc
|
18,998 | $1,252,158 | |
| 6 | INSM |
INSMED Inc
|
6,670 | $1,090,678 | |
| 7 | MRNA |
Moderna, Inc.
|
13,576 | $689,660 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
1,990 | $641,158 |
All Filings in VYGR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $79,361 | 20,560 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $144,380 | 36,738 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $179,108 | 38,353 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $128,806 | 41,417 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||